Nur Neyal, MD
@nurneyal
Followers
36
Following
104
Media
0
Statuses
24
Posdoctoral Research Fellow in Radiology & Neurology @MayoClinic | Alum @KocUniversity ‘21
Minnesota, USA
Joined June 2023
Such an honor to host the great Amit Bar-Or from @PennNeurology as visiting faculty at @MayoClinicNeuro to talk on the immunolobiology of #MS ➡️A wonderful person, outstanding researcher and superb mentor of trainees ➡️ A role model for all of us 👇
0
6
52
📣 This study provides a better understanding of the pathological mechanisms in the thalamus in MS using cellular/molecular advanced imaging modalities of MR spectroscopy and PET https://t.co/A1SJdyl2OO
0
1
8
📣Excited to share our new study on MR spectroscopy & PET in the thalamus in MS 📣Increased innate immune activity through the glial interplay of microglia and astrocytes ➡️ neurodegeneration & decreased cognitive function in MS. Thalamus on 🔥
mdpi.com
The study assesses the relationship between thalamic proton-MR spectroscopy (1H-MRS) metabolites and thalamic 11C-ER176 translocator-protein positron emission tomography (TSPO-PET) standardized...
1
1
10
"Inflammatory activity in [#MultipleSclerosis] often attenuates with aging & #androgen modifying therapies...are frequently used in older men. We aimed to investigate if number of disease activity events would increase in ≥55 years [men] with MS on AMT." https://t.co/5HoMHqkXmr
0
4
6
Proud to be one of the co-authors of this series on gender affirming care and interventions in MS. Without trying to understand all types of people living with MS, we cannot claim to provide equitable care to all.
For the International #LGBT Pride Day 🌈 have a look at the case series from @nurneyal @MayoClinic on gender-affirming interventions and prognosis in #MultipleSclerosis. 🔽 https://t.co/Q3RJAqXTW6 1/🧵
0
4
9
...and commentary from @MarcelloMoccia_ @UninaIT: We really hope this case series can support our clinical decisions and ultimately improve quality of life and health outcomes of gender-diverse people with #MultipleSclerosis. 🔽 https://t.co/rlkPWmSv4Y 2/🧵
journals.sagepub.com
0
2
4
For the International #LGBT Pride Day 🌈 have a look at the case series from @nurneyal @MayoClinic on gender-affirming interventions and prognosis in #MultipleSclerosis. 🔽 https://t.co/Q3RJAqXTW6 1/🧵
1
4
10
📣Review: 🚨Despite similar rates of #MS among Black and White individuals, RCTs report a 93% White majority➡️social >> genetic factors drive disparate MS outcomes ➡️socioeconomic disadvantage influences disability progression #DEIresearch Read more👇: https://t.co/rvR15bL95W
msard-journal.com
Multiple Sclerosis (MS) care has changed dramatically over the last three decades with scientific advancements leading to approval by the U.S. Food and Drug Administration (FDA) of more than 20...
2
4
11
Falls in people with #MultipleSclerosis are more frequent in patients who are older, have higher disability, slower walking, and worse balance. Study using patient-reported outcomes and wearable gait metrics from @SamanthaBanksMD @MayoClinicNeuro ▶️ https://t.co/FiDEmD3Upr
0
5
7
Pre-pubertal onset #MultipleSclerosis was associated with severe symptoms, greater lesion burden, higher 10-year disability, and increased relapse rates when transitioning to peri- or post-puberty. Study from @melindamagyari @Rigshospitalet @univca ▶️ https://t.co/gUO02qpqu4
0
4
9
📣Check out our study on a novel EMOJI-based patient-reported outcome measure 😁😒😴 in MS and other neurological disorders as a potential digital tool, which is fast and accessible 👩🏻💻 https://t.co/vqIoDJ6KM1
@EoinFlanagan14
link.springer.com
Journal of Neurology - Patient-reported outcome measures (PROMs) improve multiple sclerosis (MS) management by reflecting patients’ perspectives of their disease. Mayo Clinic Electronic Emoji...
1
4
22
📣📣Thalamus on FIRE🔥Thalamic microglia density on ER176 PET is highest in progressive MS followed by relapsing MS & controls. ER176 PET stands out as a promising molecular imaging biomarker of progression in MS https://t.co/DA82QZjbFH
@nurneyal @LauraAiras1
academic.oup.com
Zeydan et al. report that thalamic microglia density on 11C-ER176 PET is highest in progressive multiple sclerosis, followed by relapsing multiple sclerosi
1
7
29
Our new study👩🏻💻Men with MS >65 with prostate disease on androgen modifying therapies (AMT) may experience unexpected disease activity: AMT is not contraindicated in older men with MS but close monitoring is necessary https://t.co/kHzW1F4aT3
@JNI_Journal
0
7
10
Look up subacute sclerosing panencephalitis, Leah.
@AshleyGWinter Getting measles today is safer than the vax…. Children at that age have natural immunity from the parent antibodies still in their system and breast milk, don’t be around people who are sick with the measles
53
287
3K
Montreal Cognitive Assessment vs the Mini-Mental State Examination as a Screening Tool for Patients With Genetic Frontotemporal Dementia https://t.co/tu1lxn5FpS
#NeuroTwitter #Dementia
0
11
51
Upper cervical spinal cord atrophy was more pronounced in people with #MultipleSclerosis being older, males or menopause females, suggesting associations between hormones and neurodegeneration. Study from @burcuzeydanmd @MayoClinicNeuro @MayoClinic ▶️ https://t.co/9WhYySohBx
0
10
19
Our paper is out📣 impact of age, sex & hormones on neurodegeneration in MS➡️smaller upper cervical cord area in men than women & in postmenopausal women than premenopausal women 👩🏻💻 https://t.co/TrrowvWxH5
@MSJ_Research @nurneyal @neuronathoo @EoinFlanagan14
journals.sagepub.com
Background: Spinal cord (SC) atrophy is a key imaging biomarker of progressive multiple sclerosis (MS). Progressive MS is more common in men and postmenopausal ...
0
6
24
11.7 Tesla Brain MRI 🧠 ! First scans from the world's most powerful MRI scanner! 🔥 It costs around 75 million euros for the 11.7 Tesla MRI machine! 😮 😲 #brain #Neurology #mri #HealthAwareness #radiology
47
438
2K
👩🏻⚕️How can AI help improve and transform women’s health? Lively discussions on 🩺 AI-guided screening for cardiomyopathies 🩺 potential of virtual reality as an adjunctive therapy for pain and many other symptoms… @WHMayoClinic @DemiladeMD @ea_enningaPhD @ArvinFArani @nurneyal
0
2
15
Thrilled to share our @MayoClinicNeuro study comparing Somali Americans (SA), African Americans (AA), and White Americans (WA) with MS. SA are younger at MS onset and have similar disease severity to WA; AA fare the worst (progress younger, more EDSS6+) https://t.co/Deu1VwRqrC
1
9
26